Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MultiMetaVerse | MMV | Aug 30, 2024 | 0.56 | +2.76 |
MultiPlan A | MPLN | Aug 30, 2024 | 0.23 | -6.11 |
MultiSensor AI | MSAI | Aug 30, 2024 | 2.23 | -1.33 |
Mural Oncology | MURA | Aug 30, 2024 | 3.32 | +1.84 |
Murano Global Investments | MRNO | Aug 30, 2024 | 6.64 | +0.30 |
Murphy Oil | MUR | Aug 30, 2024 | 37.28 | -1.45 |
Murphy USA | MUSA | Aug 30, 2024 | 519.63 | +1.75 |
Mustang Bio | MBIO | Aug 30, 2024 | 0.28 | -7.07 |
MV Oil Royalty Trust | MVO | Aug 30, 2024 | 9.24 | -0.22 |
MVB Financial | MVBF | Aug 30, 2024 | 21.00 | -2.42 |
My Size | MYSZ | Aug 30, 2024 | 1.86 | -4.62 |
Myers Industries | MYE | Aug 30, 2024 | 15.29 | +0.79 |
MyMD Pharmaceuticals | MYMD | Aug 30, 2024 | 1.82 | 0.00 |
Mynaric ADR | MYNA | Aug 30, 2024 | 0.98 | +2.08 |
Mynd.Ai | MYND | Aug 30, 2024 | 1.61 | -3.01 |
Myomo | MYO | Aug 30, 2024 | 4.48 | +4.67 |
MYR Group | MYRG | Aug 30, 2024 | 100.80 | +0.79 |
Myriad Genetics | MYGN | Aug 30, 2024 | 28.33 | +0.04 |
MYT Netherlands Parent ADR | MYTE | Aug 30, 2024 | 3.73 | -4.36 |
N-able | NABL | Aug 30, 2024 | 12.86 | -0.31 |
N2OFF | NITO | Aug 30, 2024 | 0.37 | +1.16 |
Naas Technology ADR | NAAS | Aug 30, 2024 | 4.30 | +4.62 |
Nabors Energy Transition II | NETD | Aug 30, 2024 | 10.62 | 0.00 |
Nabors Energy Transition II | NETDU | Aug 30, 2024 | 10.68 | 0.00 |
Nabors Industries | NBR | Aug 30, 2024 | 75.37 | -5.37 |
NACCO Industries | NC | Aug 30, 2024 | 27.88 | -0.25 |
Nano Dimension ADR | NNDM | Aug 30, 2024 | 2.19 | +0.46 |
Nano Labs | NA | Aug 30, 2024 | 0.31 | +5.98 |
Nano Nuclear Energy | NNE | Aug 30, 2024 | 10.12 | -5.77 |
Nano-X Imaging | NNOX | Aug 30, 2024 | 6.37 | +1.43 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.